Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT
Acura Pharmaceuticals Market Cap
Acura Pharmaceuticals has a market cap or net worth of $33.25 thousand as of August 14, 2025. Its market cap has decreased by -99.87% in one year.
Market Cap
33.25K
Enterprise Value
n/a
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 17, 1986, Acura Pharmaceuticals's market cap has decreased from 7.10M to 33.25K, a decrease of -99.53%. That is a compound annual growth rate of -12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 33.25K | 150.57% |
| Dec 31, 2024 | 13.27K | 100.57% |
| Dec 29, 2023 | 6.62K | -99.80% |
| Dec 30, 2022 | 3.28M | -89.93% |
| Dec 31, 2021 | 32.54M | 615.81% |
| Dec 31, 2020 | 4.55M | -7.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 560.80M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 367.14M |
| CytoDyn | 300.75M |